Similar articles

• [Phosphodiesterases of cyclic GMP].

  Wróblewska H, Gorczyca WA. Wróblewska H, et al. Postepy Hig Med Dosw. 2001;55(5):611-27. Postepy Hig Med Dosw. 2001. PMID: 11795198 Review. Polish.
• [Modern representations of multiple forms of cyclic nucleotide phosphodiesterases in mammalian tissues].

  Medvedeva MV. Medvedeva MV. Biokhimiia. 1995 Mar;60(3):364-86. Biokhimiia. 1995. PMID: 7734612 Review. Russian.
• Cyclic nucleotides and cyclic nucleotide phosphodiesterases in kidneys from rats with experimental diabetes.

  Hoskins B, Luong HB. Hoskins B, et al. Res Commun Chem Pathol Pharmacol. 1981 Aug;33(2):381-4. Res Commun Chem Pathol Pharmacol. 1981. PMID: 6272381
• [Kinetic properties and regulation of cyclic nucleotide phosphodiesterases in lymphoid cells].

  Azhaeva EV, Severin ES. Azhaeva EV, et al. Bioorg Khim. 1987 Sep;13(9):1157-63. Bioorg Khim. 1987. PMID: 2827690 Russian.
• Relationship between inhibition of cardiac muscle phosphodiesterases, changes in cyclic nucleotide levels, and contractile response for CI-914 and other novel cardiotonics.

  Weishaar RE, Quade MM, Schenden JA, Evans DB. Weishaar RE, et al. J Cyclic Nucleotide Protein Phosphor Res. 1985;10(6):551-64. J Cyclic Nucleotide Protein Phosphor Res. 1985. PMID: 3003170